Maxalt (rizatriptan), the fourth "triptan" for migraines

September 1999

Merck Frosst is now marketing Maxalt (rizatriptan), the fourth "triptan" for migraines.

Think of Maxalt as similar to Imitrex (sumatriptan) and Zomig (zolmitriptan)...with a fast onset and short duration of action.

Amerge (naratriptan) is different. It has a slower onset...and lasts longer...to prevent RECURRENT headache.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

new approaches to controlling flu
Migraine Maxalt (rizatriptan), the fourth "triptan" for migraines
Infectious Diseases Adacel, the first diphtheria, pertussis, and tetanus (DPT) vaccine for TEENS AND ADULTS
Infectious Diseases endotoxin reactions in patients getting IV gentamicin
Pediatrics giving kids stimulants for attention deficit disorder DOESN'T increase their risk of drug abuse later on
Pediatrics encourage more parents to use infant formulas WITH IRON
St. John's wort may increase the risk of cataracts
significant interaction between warfarin and dong quai
Cholesterol RAISING low HDL cholesterol also prevents heart attack and stroke
Women's Health another option for emergency contraception, called Plan B
Hematology & Oncology lycopene might reduce the risk of prostate cancer
Hematology & Oncology Herceptin (trastuzumab) now offers a significant new approach for treating metastatic breast cancer
Renal & Urology drug that can change urine color
new antidepressant called reboxetine (Vestra, Edronax)
new sleeping pill, Sonata
Diabetes Humalog Mix25, the first insulin LISPRO mixture